Detalles de la búsqueda
1.
Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study.
Mem Inst Oswaldo Cruz
; 114: e180517, 2019 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843921
2.
Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study.
Vaccine
; 2024 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38926068
3.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Sci Rep
; 14(1): 7709, 2024 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565882
4.
Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: A retrospective observational study.
Lancet Reg Health Am
; 17: 100418, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575682
5.
The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study.
Lancet Reg Health Am
; 20: 100465, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936517
6.
A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014-2018).
Int J Infect Dis
; 108: 443-453, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33894353
7.
Duration of post-vaccination humoral immunity against yellow fever in children.
Vaccine
; 37(48): 7147-7154, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31590934
8.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 2433, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31695694
9.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Front Immunol
; 10: 2192, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31616412
10.
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 1211, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293563
11.
Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.
Mem Inst Oswaldo Cruz
; 103(7): 711-8, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19057823
12.
Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.
Vaccine
; 36(28): 4112-4117, 2018 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29784469
13.
Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants".
Hum Vaccin Immunother
; 18(1): 1894898, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010099
14.
Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
J Immunol Methods
; 448: 9-20, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28514646
15.
Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study
Mem. Inst. Oswaldo Cruz
; 114: e180517, 2019. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-990193
16.
17.
The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study
Artículo
en Inglés
| ARCA | ID: arc-58877
18.
Controvérsias sobre a ampliação das áreas com vacinação de rotina contra a febre amarela no Brasil / Controversias sobre la ampliación de las áreas con vacunación rutinaria contra la fiebre amarilla en Brasil / Controversies in the expansion of areas with routine yellow fever vaccination in Brazil
Cad. Saúde Pública (Online)
; 33(10): e00060917, oct. 2017.
Artículo
en Portugués
| LILACS | ID: biblio-952317
19.
20.